Neurocrine Biosciences (NBIX) Shares Outstanding (Entity) (2010 - 2026)
Neurocrine Biosciences (NBIX) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 834.66 Mn |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 167.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101.60 Mn |
| Mar 31, 2026 | 100.60 Mn |
| Dec 31, 2025 | 100.10 Mn |
| Sep 30, 2025 | 99.70 Mn |
| Jun 30, 2025 | 99.00 Mn |
| Mar 31, 2025 | 99.00 Mn |
| Dec 31, 2024 | 99.40 Mn |
| Sep 30, 2024 | 101.20 Mn |
| Jun 30, 2024 | 100.90 Mn |
| Mar 31, 2024 | 100.60 Mn |
| Dec 31, 2023 | 98.70 Mn |
| Sep 30, 2023 | 98.20 Mn |
| Jun 30, 2023 | 97.60 Mn |
| Mar 31, 2023 | 97.50 Mn |
| Dec 31, 2022 | 96.50 Mn |
| Sep 30, 2022 | 96.10 Mn |
| Jun 30, 2022 | 95.60 Mn |
| Mar 31, 2022 | 95.50 Mn |
| Dec 31, 2021 | 94.90 Mn |
| Sep 30, 2021 | 94.80 Mn |